Podcast Episodes
Back to Search
Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will revie…
2 months, 1 week ago
Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers
Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact…
2 months, 2 weeks ago
Author Interview: Doctor Carlo Tur, February 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor Carlo Tur, from the department of Medicine 3-Rheumatology and Immunolo…
2 months, 3 weeks ago
Author Interview - Professor Andrew Cope, 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College …
3 months ago
Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will revie…
3 months, 1 week ago
Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘cla…
3 months, 3 weeks ago
Author Interview: Professor Matthew Brown, 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Matthew Brown, the Chief Scientific Officer at Genomics England, as…
4 months ago
Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will revie…
4 months ago
Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he and Doctor…
5 months, 2 weeks ago
Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covere…
5 months, 3 weeks ago